Cancer vaccine induces potent T cell responses — but is it enough?

Anjali Rohatgi; John M. Kirkwood

doi:10.1038/s41571-020-00437-1

Cancer vaccine induces potent T cell responses — but is it enough?

Anjali Rohatgi
, John M. Kirkwood

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	721-722
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	17
Issue number	12
DOIs	https://doi.org/10.1038/s41571-020-00437-1
State	Published - Dec 2020

Access to Document

10.1038/s41571-020-00437-1

Cite this

@article{eaa08def71734b6398ff4a4072f24e6e,

title = "Cancer vaccine induces potent T cell responses — but is it enough?",

author = "Anjali Rohatgi and Kirkwood, \{John M.\}",

note = "Funding Information: J.M.K. has received grants and personal fees for consultancy from Amgen, Bristol-Myers Squibb, Checkmate and Novartis, and grants from Castle Biosciences, Immunocore and Iovance. A.R. declares no competing interests. Funding Information: The work of the authors is supported by the NIH National Cancer institute SPORE in Skin Cancer grant P50 CA-121973.",

year = "2020",

month = dec,

doi = "10.1038/s41571-020-00437-1",

language = "English",

volume = "17",

pages = "721--722",

journal = "Nature Reviews Clinical Oncology",